Screening for prostatic cancer
Laufer, M.; Matzkin, H.; Braf, Z.F.
Harefuah 129(1-2): 39-43
1995
ISSN/ISBN: 0017-7768 PMID: 7557708 Document Number: 453878
Document emailed within 1 workday
Related Documents
Nakagawa, S.; Watanabe, M.; Nomoto, T.; Sugimoto, K.; Mikami, K.; Ebisui, K.; Kitamura, K.; Kojima, M.; Saitoh, M.; Watanabe, H. 1997: Mass screening for prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 43(6): 447-452Maksimov, V.A.; Pushkar', D.Iu.; Umarov, M.S. 2009: Current outlook on screening of prostatic cancer Urologiia 2009(5): 74-77
Dige, U. 2004: Grey zone-screening for prostatic cancer Ugeskrift for Laeger 166(50): 4619; Author Reply 4619-20
Nakagawa, S. 2002: Evaluation of mass screening for prostatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 289-293
Ito, K.; Ohtake, N.; Hatori, M.; Mashimo, T.; Jimbo, S.; Tomaru, Y.; Makino, T.; Yajima, H.; Imai, K.; Yamanaka, H. 1992: Prostatic specific antigen (PA) in mass screening for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1225-1229
Varenhorst, E.; Carlsson, P.; Löfman, O.; Capik, E.; Pedersen, K. 1992: Knowledge about effectiveness of general screening for prostatic cancer is limited Lakartidningen 89(45): 3835-3838
Corbusier, A.; Vanden Bossche, M.; Mendes Leal, A.; Simon, J.; Wespes, E.; Van Regemorter, G.; Schulman, C.C. 1989: Reliability of endorectal echography of the prostate in the screening and staging of prostatic cancer Acta Urologica Belgica 57(4): 831-841
Varenhorst, E.; Carlsson, P.; Hagström, I.; Lindahl, T.; Löfman, O.; Brage, H.N.; Pedersen, K.; Wägermark, J. 1996: Experiences from six years' examinations of prostatic cancer. Mass screening is not of immediate interest! Lakartidningen 93(35): 2940-2946
Luján Galán, M.; Páez Bordá, A.; Llanes González, L.; Fernández González, I.; Moreno Santurino, A.; Berenguer Sánchez, A. 2000: Characteristics of prostatic cancer undetected in the first assessment of a screening program. Quality control Archivos Espanoles de Urologia 53(10): 900-904
Muzzonigro, G.; Beatrici, V.; Diambrini, M.; Minardi, D.; Rosciani, C.; Possati, L.; Polito, M. 1988: Biology and natural history of prostatic cancer: necessity of early diagnostic screening Bollettino della Societa Italiana di Biologia Sperimentale 64(6): 555-561
Bratt, O.; Abrahamsson, P.A.; Lundgren, R.; Olsson, H.; Kristoffersson, U. 1998: Research progress on hereditary prostatic cancer. Families at risk should be surveyed and screening should be offered Lakartidningen 95(14): 1494-1496
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258